Full Press Release Details
Tiziana Life Sciences
Date Scheduled for July, 09 2021
IS FOR US ADS HOLDERS ONLY
New York, 8 July 2021 - Tiziana Life Sciences
plc (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology,
inflammation and infectious diseases, today announces that its American Depository Shares ("ADS"), trading under the ticker
TLSA, will begin trading ex-dividend on July 09, 2021.
dividend, in the form of an in-specie dividend of one Accustem Sciences Limited ADS (representing 2 ordinary shares in Accustem Sciences
Limited) per TLSA ADS, is scheduled to be paid on July 14, 2021.
who purchased TLSA prior to the ex-dividend date are eligible for the non-cash dividend.
Holders of TLSA should also refer to the notice
published by JP Morgan, the ADR depositary bank which can be found at https://www.adr.com/drprofile/88875G101
For further enquiries:
| Tiziana Life Sciences plc Gabriele Cerrone, Chairman and founder | +44 (0)20 7495 2379 |
| United States: Investors: Dave Gentry, CEO RedChip Companies Inc. 1-800-RED-CHIP (733-2447) or 407-491-4498 dave@redchip.com |